1) Selling to--and selling out--children
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 959
The Lancet

2) WHO'S mandate: a damaging reinterpretation is taking place
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 960-961
Richard Horton

3) Surgery or stent? The gap continues to narrow
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 961-962
William W O'Neill, Cindy L Grines

4) Nonoxynol-9 fails to prevents STDs, but microbicide research continues
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 962-963
David Wilkinson

5) Accidental superwarfarin poisoning in children--less treatment is better
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 963
Dipak Kanabar, Glyn Volans

6) Virtual colonoscopy
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 964
Marc J Gollub

7) Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 965-970
The SoS Investigators

8) Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 971-977
Lut Van Damme, Gita Ramjee, Michel Alary, Bea Vuylsteke, Verapol Chandeying, Helen Rees, Pachara Sirivongrangson, Leonard Mukenge Tshibaka, Virginie Ettiegne-Traore, Charn Uaheowitchai, Salim S Abdool Karim, Benoit Masse, Jos Perriens, Marie Laga and on behalf of the COL-1492 study group

9) Chronic coccidioidomycosis
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 977
Akihiro Tsukadaira, Yoshio Okubo, Etsuro Sato, Keishi Kubo

10) Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 978-984
A Equi, IM Balfour-Lynn, A Bush, M Rosenthal

11) Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 985-990
Chifumbe Chintu, Victor Mudenda, Sebastian Lucas, Andrew Nunn, Kennedy Lishimpi, Daniel Maswahu, Francis Kasolo, Peter Mwaba, Ganapati Bhat, Hiroshi Terunuma, Alimuddin Zumla and for the UNZA-UCLMS Project Paediatric Post-mortem Study Group

12) Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 991-995
Thomas Hohler, Esther Reuss, Nina Evers, Evi Dietrich, Christian Rittner, Christine M Freitag, Jens Vollmar, Peter M Schneider, Rolf Fimmers

13) Urinary tract infection and coma
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 996
Bernard De Jonghe, Virginie Janier, Nassim Abderrahim, Daniel Hillion, Jean-Claude Lacherade, Herve Outin

14) Variant Creutzfeldt-Jakob disease in an Italian woman
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 997-998
Vincenzo La Bella, John Collinge, Maurizio Pocchiari, Federico Piccoli

15) Prenatal exclusion of [beta] thalassaemia major by examination of maternal plasma
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 998-1000
Rossa WK Chiu, Tze K Lau, Tse N Leung, Katherine CK Chow, David HK Chui, YM Dennis Lo

16) Marketing and advertising: harmful to children's health
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1001
Faith McLellan

17) Adenotonsillar disease has a detrimental effect on children's quality of life
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1002
Roxanne Nelson

18) Researchers uncover clues to mechanism of pain sensitivity
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1002
Kathryn Senior

19) Explanation found for 'glitazone paradox'
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1003
Jane Bradbury

20) Retrospective data strengthen Alzheimer's link with aspirin and NSAIDs
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1003
David Lawrence

21) Blair says UK dossier points to Iraq's missile capacity
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1004
Sarah Ramsay

22) Southeast Asian countries vie with each other to woo foreign patients
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1004
Vivien Choo

23) UN agency resumes food aid in Uganda despite attacks
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1005
Charles Wendo

24) london UK opposition tempts public with new health plans
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1006
Malcolm Dean

25) BRCA1: mechanisms of inactivation and implications for management of patients
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 1007-1014
Richard D Kennedy, Jennifer E Quinn, Patrick G Johnston, D Paul Harkin

26) Prevention of coronary heart disease in south Asia
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 1015-1018
Sania Nishtar

27) A guide to microarray experiments-an open letter to the scientific journals
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1019
On the behalf of Microarray Gene Expression Data (MGED), Catherine A Ball, Gavin Sherlock, Helen Parkinson, Philippe Rocca-Sera, Catherine Brooksbank, Helen C Causton, Duccio Cavalieri, Terry Gaasterland, Pascal Hingamp, Frank Holstege, Martin Ringwald, Paul Spellman, Christian J Stoeckert Jr, Jason E Stewart, Ronald Taylor, Alvis Brazma, John Quackenbush

28) A guide to microarray experiments--an open letter to the scientific journals
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1019

29) Immunity against hepatitis C virus infection
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 1019-1020
Gregory J Dore, Anthony J Freeman, John M Kaldor

30) Immunity against hepatitis C virus infection
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1020
Jeffrey J Post, Anthony J Freeman, Charles E Harvey, Rosemary A Ffrench, Andrew R Lloyd

31) Immunity against hepatitis C virus infection
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 1020-1021
Shruti H Mehta, Andrea L Cox, Steffanie A Strathdee, David Vlahov, David L Thomas

32) Measurement of red blood cell methylfolate
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 1021-1022
Mark Lucock, Zoe Yates

33) Measurement of red blood cell methylfolate
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1022
Isabelle Quere, Jacqueline Zittoun, Jean-Christophe Gris, Charles Janbon, Philippe de Moerloose

34) Quality of evidence for management of arteriovenous malformations of the brain
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 1022-1023
Rustam Al-Shahi, Charles P Warlow

35) Quality of evidence for management of arteriovenous malformations of the brain
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1023
Gary K Steinberg, Ian G Fleetwood

36) Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 1023-1024
Fabio Mosca, Milena Bray, Ilaria Stucchi, Monica Fumagalli

37) Phosphine poisoning by proxy
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1024
John BP Stephenson

38) ARH mutations and hypercholesterolaemia in Sardinia
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1024
Joel Zlotogora

39) ARH mutations and hypercholesterolaemia in Sardinia
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1024
Jonathan Cohen, Helen H Hobbs

40) Use of Wau Wa in dermatitis patients
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1025
Justin Daniels, Debbie Shaw, David Atherton

41) Supply of opiates from UK for children in African hospitals
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1025
Peter McCormick

42) How many committees does it take to make a project ethical?
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 1025-1026
Robert H Gilman, Catherine Anderton, Margaret Kosek, Hector H Garcia, Carton A Evans

43) Risk assessment for Creutzfeldt-Jakob disease
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1026
JK Struthers, MJ Weinbren, J Lockwood, S Glancy, NH O'Connell

44) A magisterial valedictory
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1027
Kevin Padian

45) A stitch in time
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1028
Shaun Caton

46) Plague in the cardiovascular system
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Pages 1028-1029
Robert A Harrington

47) Websites in brief
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1029
Marilynn Larkin

48) Antoine Danchin
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1030

49) The new policy
The Lancet, Volume 360, Issue 9338, , 28 September 2002, Page 1030
Larry Greenbaum